Clinical Trials

25 enrolled 23 charts

Familial ependymoma, Ependymoma, Recurrence

NCT01247922 2024-12-06

Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205

4 enrolled 9 charts

Familial ependymoma, Ependymoma

NCT00750698 2023-07-06

A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib

8 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00597597 2023-05-17

Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer

11 enrolled 12 charts

Breast

Breast Neoplasms

NCT02714530 2021-03-30

ThoRaT

118 enrolled

Neoplasms

NCT00760929 2021-01-05

A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

171 enrolled 17 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT02318368 2020-10-22

FOCAL

10 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT01038856 2020-08-24

OSI-TAR-766

5 enrolled 6 charts

Myeloid

Polycythemia Vera

NCT01857271 2020-07-08

EVENT

3 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT02169284 2020-07-07

Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery

50 enrolled 27 charts

Genitourinary

Urinary Bladder Neoplasms

NCT01192815 2020-05-12

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck

2 enrolled 8 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00539617 2020-03-23

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

7 enrolled 9 charts

Esophageal Neoplasms

NCT02117024 2020-02-05

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

66 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02770014 2019-11-22

Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer

43 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT01182350 2019-09-04

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

53 enrolled 12 charts

CNS

Diffuse Intrinsic Pontine Glioma

NCT01822496 2019-08-05

Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

59 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT01518621 2019-03-13

RadEr

25 enrolled

Neoplasms

NCT01962896 2019-02-26

A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors

4 enrolled 6 charts

Neoplasms, Germ Cell and Embryonal

NCT01376310 2019-02-19

GSK1120212 Rollover Study

159 enrolled 9 charts

Neoplasms

NCT00276744 2018-10-24

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

249 enrolled 4 charts

Pancreatic Neoplasms

NCT00832637 2018-06-29

Gem-ox

33 enrolled 9 charts

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT00281021 2018-03-29

Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer

26 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT00841035 2017-05-19

7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients

6 enrolled 3 charts

Neoplasms, Pancreatic Neoplasms

NCT00392665 2017-04-13

Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck

36 enrolled 10 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00947167 2017-03-03

A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors

4 enrolled 5 charts

CNSEndocrineNET

Adrenal Gland Neoplasms, Carcinoid Tumor, Multiple Endocrine Neoplasia, Neuroblastoma, Neuroendocrine Tumors

NCT01108458 2017-03-03

A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma

1 enrolled 4 charts

Pancreatic Neoplasms

NCT02095782 2017-03-03

INNOVATE

10 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00470535 2017-02-23

Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer

18 enrolled 6 charts

Pancreatic Neoplasms

NCT00336700 2016-09-19

A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer

25 enrolled 10 charts

Neoplasms, Pancreatic Neoplasms

NCT01003938 2016-06-30

Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer

6 enrolled 7 charts

Gynecologic

Ovarian Neoplasms

NCT00766636 2016-05-19

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

5 enrolled 6 charts

Pancreatic Neoplasms

NCT00063258 2016-05-09

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

5 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00532441 2016-02-12

Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas

25 enrolled 13 charts

Carcinoma, Hepatocellular

NCT00988169 2015-11-20

Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

6 enrolled 6 charts

Lung Neoplasms

NCT01189435 2015-11-18

Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib

2 enrolled 3 charts

Lung Neoplasms, Recurrence

NCT00749567 2015-09-28

Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer

13 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00391586 2015-08-17

Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung

45 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01009203 2015-08-10

Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma

13 enrolled 8 charts

Carcinoma, Squamous Cell

NCT00442507 2015-07-24

OSI3650

6 enrolled 7 charts

Esophageal Diseases, Esophageal Neoplasms

NCT00452075 2014-12-11

Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy

24 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00482625 2014-10-16

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

6 enrolled 8 charts

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT00642746 2014-09-26

Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)

16 enrolled 9 charts

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT00976677 2014-05-30

Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer

10 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung

NCT00636883 2014-01-22

GEMOX-T

9 enrolled

Pancreatic Neoplasms

NCT00773383 2013-06-24

A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.

35 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00087269 2013-06-06

Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection

110 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00387894 2013-06-04

Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

6 enrolled 10 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00047333 2013-01-23

Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed

80 enrolled

Carcinoma, Hepatocellular

NCT01205685 2012-09-11

Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer